111 (NASDAQ:YI) Director Yang Luke Chen Sells 49,920 Shares

111, Inc. Sponsored ADR (NASDAQ:YI) Director Yang Luke Chen sold 49,920 shares of 111 stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $0.23, for a total value of $11,481.60. Following the completion of the sale, the director directly owned 539,462 shares in the company, valued at approximately $124,076.26. This represents a 8.47% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Yang Luke Chen also recently made the following trade(s):

• On Monday, June 15th, Yang Luke Chen sold 44,000 shares of 111 stock. The stock was sold at an average price of $0.23, for a total value of $10,120.00.
• On Wednesday, May 27th, Yang Luke Chen sold 3,400 shares of 111 stock. The shares were sold at an average price of $0.25, for a total value of $850.00.
• On Tuesday, May 26th, Yang Luke Chen sold 1,440 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $388.80.

111 Trading Down 2.6%

NASDAQ YI opened at $4.45 on Wednesday. The firm has a market capitalization of $39.09 million, a P/E ratio of -3.18 and a beta of 0.60. The firm’s fifty day moving average price is $5.84 and its two-hundred day moving average price is $5.67. 111, Inc. Sponsored ADR has a 1 year low of $2.48 and a 1 year high of $11.17.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, 111 currently has an average rating of “Sell”.

About 111

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.